VAERS reports by lot

GSK Varicella/Shingles lot C5E43: VAERS reports

42 VAERS reports list lot C5E43 as a GSK Varicella/Shingles vaccine, received between 2019-05-01 and 2021-02-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
42
Reports
5%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4331%
General / Systemic (non-local)3021%
Dermatological (non-injection-site)1712%
Musculoskeletal1611%
Neurological1410%
Allergic / Anaphylactic86%
Cardiac / Cardiovascular54%
Gastrointestinal32%
Respiratory21%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
Michigan5
Illinois3
Kansas2
Arizona2
Massachusetts2
California2
New Mexico2
Connecticut1
Tennessee1
Alabama1
Oklahoma1

Reports by month received

2019-0514
2019-0611
2019-074
2019-084
2019-091
2019-112
2020-011
2020-033
2020-071
2021-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.